Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

KCI Preps Silver-Coated Wound Dressing For Q3 Market Introduction

This article was originally published in The Gray Sheet

Executive Summary

Kinetic Concepts plans to launch a silver-coated anti-bacterial wound dressing in August to sell at a premium to standard dressings

You may also be interested in...



Vacuum Wound Closure Randomized Trials Target Data Gaps Outlined By AHRQ

Kinetic Concepts is conducting 10 randomized trials of its V.A.C. vacuum-assisted wound closure device to address gaps in existing efficacy data outlined in a recent AHRQ tech assessment

Silzone Class Action Against St. Jude Can Go Forward, Minnesota Judge Rules

An approved PMA supplement for St. Jude Medical's Silzone heart valve does not preempt product liability suits, since there is evidence that the firm concealed problems with the device, according to a Jan. 7 ruling

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel